Pharmacist's role in a Parkinson's disease and movement disorders clinic

被引:13
作者
Poon, Linda H. [1 ,2 ,3 ]
Lee, Audrey J. [3 ]
Chiao, Teresa B. [2 ]
Kang, Gail A. [4 ,5 ]
Heath, Susan [6 ]
Glass, Graham A. [6 ,7 ]
机构
[1] San Francisco Vet Affairs Med Ctr VAMC, San Francisco, CA USA
[2] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA
[3] Univ Pacific, Thomas J Long Sch Pharm & Hlth Sci, Stockton, CA 95211 USA
[4] Univ Calif San Francisco, Neurol Memory & Aging Ctr, San Francisco, CA 94143 USA
[5] San Francisco VA Med Ctr, Educ & Clin Ctr PADRECC, San Francisco, CA USA
[6] San Francisco VA Med Ctr, PADRECC, San Francisco, CA USA
[7] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
关键词
Ambulatory care; Clinical pharmacists; Clinical pharmacy; Department of Veterans Affairs; Movement disorders; Parkinson disease; Patient information; Pharmaceutical services; Team; MANAGEMENT;
D O I
10.2146/ajhp110127
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The expanding role of a clinical pharmacist at a Veterans Affairs (VA) outpatient clinic for patients with Parkinson's disease (PD) and movement disorders is described. Summary. San Francisco VA Medical Center added a clinical pharmacist to the multidisciplinary team serving patients at an outpatient clinic operated by its Parkinson's Disease Research, Education and Clinical Center (PADRECC). During the first six months after joining the clinic team, the pharmacist met with 131 patients and made a total of 69 drug therapy recommendations that were implemented by neurologists, clinical nurse specialists, and other PADRECC providers. The results of a retrospective chart review suggested that in about 21% of the cases evaluated, the pharmacist's recommendations contributed to an improved medical outcome or the resolution of a medical problem. Anonymous surveys indicated that clinic providers (n = 33) and patients (n = 20) were satisfied with the pharmacist's services. Using a five-point Likert scale (scores ranged from 1 for "strongly disagree" to 5 for "strongly agree") that they had more time to devote to other clinic responsibilities with the pharmacist present in the clinic (mean score, 4.79); patients indicated that they had an improved understanding of their medications after speaking with the pharmacist (mean score, 4.88). Conclusion. A clinical pharmacist's regular involvement in an outpatient PD and movement disorders clinic has been well received by patients and clinic providers. The study results suggest that the pharmacist has made important contributions in areas such as therapeutic problem solving and medication education while freeing up providers for other responsibilities.
引用
收藏
页码:518 / 520
页数:3
相关论文
共 10 条
[1]  
Chen JJ, 2010, AM J MANAG CARE, V16, pS87
[2]  
Chen JJ, 2005, CONSULT PHARM, V20, pS22
[3]   Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden [J].
Midlöv, P ;
Bondesson, Å ;
Eriksson, T ;
Petersson, J ;
Minthon, L ;
Höglund, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 57 (12) :903-910
[4]  
National Parkinson Foundation, PARK DIS OV
[5]  
O'Maley K, 2005, NURS OLDER PEOPLE
[6]  
O'Maley K, 2005, NURS OLDER PEOPLE
[7]  
O'Maley Karen, 2005, Nurs Older People, V17, P14
[8]   Role of the pharmacist in the effective management of wearing-off in Parkinson's disease [J].
Simonson, William ;
Hauser, Robert A. ;
Schapira, Anthony H. V. .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (11) :1842-1849
[9]  
Syfrett M, 2001, CONSULT PHARM, V16, P137
[10]  
Young LR, 2000, AM J MANAG CARE, V6, P93